PTIN - ETF AI Analysis
Top Page
Pacer Trendpilot International ETF (PTIN)
PTIN, the Pacer Trendpilot International ETF, has a solid overall rating driven largely by high-quality global leaders like Novartis, HSBC, and AstraZeneca, which bring strong financial performance, positive earnings outlooks, and generally supportive technical trends. The fund also benefits from stable, well-established names such as Nestlé, Roche, and Shell, though some face valuation concerns, potential overbought technical conditions, or slower revenue and cash flow growth, which modestly hold back the ETF’s rating. A key risk factor is the fund’s reliance on a relatively small group of large international companies, meaning issues at a few major holdings could have an outsized impact on performance.
PTIN vs. SPDR S&P 500 ETF (SPY)
- AUM
- 174.99M
- Region
- Developed Markets
- Expense Ratio
- 0.65%
- Beta
- 0.72
- Issuer
- Pacer
- Inception Date
- May 02, 2019
- Dividend Yield
- 2.30%
- Asset Class
- Equity
- Index Tracked
- Pacer Trendpilot International Index
PTIN Summary
Pacer Trendpilot International ETF (PTIN) is an international stock fund that follows the Pacer Trendpilot International Index. It invests in large, well-established companies outside the U.S., across many countries like Japan, the UK, and Canada, and a mix of sectors including financials, technology, and health care. Well-known holdings include Samsung Electronics, ASML, HSBC, Shell, Novartis, and Nestlé. The fund’s “trendpilot” approach can shift between stocks and cash, aiming for growth while trying to reduce big losses. A key risk is that international stock prices can still go up and down with global markets, and the strategy may not always protect against declines.
How much will it cost me?
PTIN has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 invested. This cost is higher than the average ETF because it uses an active Trendpilot strategy that shifts between stocks and cash based on market signals, rather than simply tracking a basic index.
What would affect this ETF?
PTIN could benefit if developed markets outside the U.S. grow steadily, especially in technology, financials, and health care, which would support major holdings like Samsung, ASML, and large global banks, and its trend-following strategy may help it stay invested during strong uptrends. On the downside, global slowdowns, higher interest rates, or market stress in Europe and Asia could hurt banks, chipmakers, and energy companies, and frequent shifts between stocks and cash might lag markets if trends reverse quickly.
PTIN Top 10 Holdings
PTIN is leaning heavily on a handful of international heavyweights, with Samsung Electronics acting as a steady anchor while chip makers ASML and SK hynix add more volatile, trend-driven fuel to returns. Health care names like Roche and Novartis are quietly rising, helping smooth out the ride when financials wobble. On the flip side, HSBC has been lagging lately, and consumer staple giant Nestlé has been mixed, slightly dulling the fund’s shine. Overall, it’s a developed-markets ex-U.S. story, with a clear tilt toward global tech, pharma, and big banks.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 KR:005930 | Samsung Electronics | 3.00% | $5.25M | KRW 1204.42T | 90.22% | ―― |
 KR:000660 | SK hynix Inc. | 2.41% | $4.22M | KRW 825.08T | 90.89% | ―― |
 NL:ASML | ASML Holding NV | 2.38% | $4.16M | EUR 490.32B | 43.37% | 76Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 GB:HSBA | HSBC Holdings | 1.32% | $2.32M | GBP 223.53B | 19.82% | 80Outperform |
 CH:NOVN | Novartis AG | 1.31% | $2.30M | CHF 243.61B | 30.57% | 80Outperform |
 GB:SHEL | Shell (UK) | 1.28% | $2.25M | GBP 211.09B | 30.61% | 73Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 RY | Royal Bank Of Canada | ― | ― | ― | ― | 75Outperform |
 CH:NESN | Nestlé SA | 1.20% | $2.10M | CHF 220.83B | 8.82% | 71Outperform |
PTIN Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PTIN, the sentiment is Negative. The current price of 34.72 is below the 20-day moving average (MA) of 35.72, below the 50-day MA of 36.53, and below the 200-day MA of 35.64, indicating a bearish trend. The MACD of -0.33 indicates Positive momentum. The RSI at 35.81 is Neutral, neither overbought nor oversold. The STOCH value of 29.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PTIN.
PTIN Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| PTIN | $34.72 | $37.00(6.57% Upside) | $174.99M | 0.65% | 62Neutral |
 TILC | $24.40 | $28.51(16.86% Upside) | $924.40M | 0.52% | 63Neutral |
 FYLD | $38.76 | $42.83(10.50% Upside) | $760.46M | 0.59% | 62Neutral |
 ISCF | $42.94 | ― | $704.96M | 0.23% | 57Neutral |
 TPIF | $37.02 | $42.02(13.49% Upside) | $275.72M | 0.62% | 59Neutral |
 TLCI | $28.32 | $32.66(15.30% Upside) | $118.92M | 0.37% | 61Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PTIN | Pacer Trendpilot International ETF | 34.72 | 3.85 | 12.47% | |
| TILC | Thrivent International Large Cap ETF | 24.40 | -0.95 | -3.74% | |
| FYLD | Cambria Foreign Shareholder Yield ETF | 38.76 | 7.91 | 25.64% | |
| ISCF | iShares MSCI Intl Small-Cap Multifactor ETF | 42.94 | 3.83 | 9.80% | |
| TPIF | Timothy Plan International ETF | 37.02 | 3.79 | 11.42% | |
| TLCI | Touchstone International Equity ETF | 28.32 | 2.32 | 8.91% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.